4,500 units subcutaneously daily or 75 units/kg subcutaneously daily for prophylaxis.
Low molecular weight heparin indicated for use in patients with cancer.
4,500 units subcutaneously daily or 75 units/kg subcutaneously daily for prophylaxis.
Low molecular weight heparin indicated for use in patients with cancer.